Age, median (range) | 74.1 (40.5–88.8) |
---|---|
Sex, n (%) | |
Male | 48 (90.6%) |
Female | 5 (9.4%) |
Primary or recurrence, n (%) | |
Primary | 42 (79.2%) |
Recurrence | 11 (20.8%) |
Recurrence within one year, n (%) | |
Yes | 9 (17.0%) |
No | 44 (83.0%) |
Tumor grade, n (%) | |
Low | 39 (73.6%) |
High | 14 (26.4%) |
T stage, n (%) | |
pTa | 42 (79.2%) |
pT1 | 11 (20.8%) |
Number of tumor, n (%) | |
Single | 24 (45.3%) |
Multiple | 29 (54.7%) |
Tumor size, n (%) | |
< 3 cm | 46 (86.8%) |
≥ 3 cm | 7 (13.2%) |
Concurrent CIS, n (%) | |
Yes | 2 (3.8%) |
No | 51 (96.2%) |
Immediate intravesical chemotherapy, n(%) | |
Yes | 51 (96.2%) |
No | 2 (3.8%) |
Additional adjuvant intravesical chemotherapy, n (%) | |
Yes | 12 (22.6%) |
No | 41 (77.4%) |
Second TUR, n (%) | |
Yes | 6 (11.5%) |
No | 47 (88.5%) |